<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors investigated whether the considerable variability in serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels (STB) found in transfusion-dependent <z:e sem="disease" ids="C0005283" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia</z:e>, beta-thal intermedia, and heterozygous <z:e sem="disease" ids="C0005283" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia</z:e> individuals could be related to the coexistence of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> (GS) </plain></SENT>
<SENT sid="1" pm="."><plain>The promoter region [A(TA)nTAA] of the <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase gene (UGT1A1) was analyzed in a total of 128 beta-<z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> individuals (108 transfusion-dependent beta-thal patients, 20 very mild beta-thal intermedia) and in 33 beta-thal heterozygotes </plain></SENT>
<SENT sid="2" pm="."><plain>The control group consisted of 70 healthy children with no history of <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The frequency of GS genotype (TA)7/(TA)7 did not differ significantly between the groups studied </plain></SENT>
<SENT sid="4" pm="."><plain>A significant difference was observed between serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels (STB) and GS genotypes (TA)7/(TA)7 and (TA)6/(TA)7 and also between (TA)7/(TA)7 and (TA)6/(TA)6 for <z:hpo ids='HP_0000001'>all</z:hpo> groups examined </plain></SENT>
<SENT sid="5" pm="."><plain>These results confirm that the (TA)7/(TA)7 GS genotype is one of the factors accounting for the <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> observed in <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia major</z:e>, intermedia, and heterozygous individuals </plain></SENT>
</text></document>